Davide Casagrandi
Overview
Explore the profile of Davide Casagrandi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zidan Sweid R, Donadono V, Casagrandi D, Sarno L, Attilakos G, Pandya P, et al.
Arch Gynecol Obstet
. 2025 Jan;
PMID: 39821448
Objectives: To produce standards of references for quality control and assess the reproducibility of fetal ultrasound Doppler measurements commonly used for blood flow assessment in fetal growth. Methods: Women with...
2.
Ivan M, Mahdy H, Banerjee A, Tetteh A, Greenwold N, Casagrandi D, et al.
J Ultrasound Med
. 2024 Nov;
44(3):509-519.
PMID: 39508476
Objective: To assess the reproducibility of standardized 3-dimensional (3D) ultrasound volume analysis of the dimensions and the position of cesarean birth (CB) scar niche relative to the cervix in pregnant...
3.
Banerjee A, Ivan M, Nazarenko T, Solda R, Bredaki E, Casagrandi D, et al.
Am J Obstet Gynecol MFM
. 2024 Jan;
6(3):101298.
PMID: 38278178
Background: A previous term (≥37 weeks' gestation), full-dilatation cesarean delivery is associated with an increased risk for a subsequent spontaneous preterm birth. The mechanism is unknown. We hypothesized that the...
4.
Nzelu D, Palmer T, Stott D, Pandya P, Napolitano R, Casagrandi D, et al.
BJOG
. 2023 Jul;
131(2):222-230.
PMID: 37431533
Objective: Investigate cost-effectiveness of first trimester pre-eclampsia screening using the Fetal Medicine Foundation (FMF) algorithm and targeted aspirin prophylaxis in comparison with standard care. Design: Retrospective observational study. Setting: London...
5.
Donadono V, Ambroise Grandjean G, Stegen M, Collin A, Bertholdt C, Casagrandi D, et al.
J Ultrasound Med
. 2022 Mar;
41(11):2819-2825.
PMID: 35302655
Objectives: To assess the intra- and interobserver reproducibility of fetal biometry measurements obtained by trainee (junior) and experienced sonographers (senior) in the contest of two training programs in obstetric ultrasound....
6.
Kunpalin Y, Burul G, Greenwold N, Tetteh A, Casagrandi D, Warner D, et al.
Eur J Obstet Gynecol Reprod Biol
. 2020 Jun;
251:141-145.
PMID: 32505054
Objectives: Cervical cerclage is used to manage women at high risk of late miscarriage (LM) and spontaneous preterm birth (PTB) due to factors such as history of cervical insufficiency (CI),...
7.
Akolekar R, Casagrandi D, Livanos P, Tetteh A, Nicolaides K
Prenat Diagn
. 2009 Jul;
29(10):934-8.
PMID: 19565609
Objective: To investigate whether in pregnancies that subsequently develop preeclampsia (PE), the maternal plasma concentration of the inflammatory factor pentraxin 3 (PTX3) at 11-13 weeks of gestation is increased and...
8.
Akolekar R, Casagrandi D, Skyfta E, Ahmed A, Nicolaides K
Prenat Diagn
. 2009 Jun;
29(9):847-51.
PMID: 19499513
Objective: In women with preeclampsia (PE), the serum concentration of the growth factor angiopoietin-2 (Ang-2) is significantly lower than in unaffected controls. The objective of this study is to determine...